Acceptability of manufacturer proposed utility values for NICE cancer medicine appraisals: analysis of manufacturers’ information sources

Physician's Weekly

21 March 2022 - The NICE method guide for technology appraisals encourages medicine manufacturers to use the EuroQol 5 Dimension in relevant clinical trials to obtain utility values; however, the EQ-5D may have low sensitivity when compared to disease-specific measures. 

This study investigated whether the NICE Technology Appraisal Committee’s acceptance of manufacturer-proposed utility values is dependent on the manufacturers’ sources of the utility values.

Read Physician's Weekly article

Michael Wonder

Posted by:

Michael Wonder